Literature DB >> 30414909

Are Bacteria Infectious Pathogens in Hidradenitis Suppurativa? Debate at the Symposium for Hidradenitis Suppurativa Advances Meeting, November 2017.

Haley B Naik1, Aude Nassif2, Mayur S Ramesh3, Gregory Schultz4, Vincent Piguet5, Afsaneh Alavi5, Michelle A Lowes6.   

Abstract

In November 2017, a formal debate on the role of bacteria in the pathogenesis of hidradenitis suppurativa (HS) was held at the 2nd Symposium on Hidradenitis Suppurativa Advances (SHSA) in Detroit, Michigan. In this report, we present both sides of the argument as debated at the SHSA meeting and then discuss the potential role of bacteria as classic infectious pathogens versus an alternative pathogenic role as activators of dysregulated commensal bacterial-host interactions. Although there was consensus that bacteria play a role in pathogenesis and thus are pathogenic, there was a compelling discussion about whether bacteria in HS incite an infectious disease as we classically understand it or whether bacteria might play a different role in HS pathogenesis.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30414909      PMCID: PMC8171295          DOI: 10.1016/j.jid.2018.09.036

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  25 in total

1.  The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.

Authors:  Hessel H van der Zee; Jurr Boer; Errol P Prens; Gregor B E Jemec
Journal:  Dermatology       Date:  2009-07-08       Impact factor: 5.366

2.  Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.

Authors:  P D Shenefelt
Journal:  Cutis       Date:  1996-05

3.  Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients.

Authors:  V Bettoli; S Zauli; A Borghi; G Toni; S Minghetti; M Ricci; A Virgili
Journal:  J Eur Acad Dermatol Venereol       Date:  2013-03-02       Impact factor: 6.166

Review 4.  Biofilms: an emergent form of bacterial life.

Authors:  Hans-Curt Flemming; Jost Wingender; Ulrich Szewzyk; Peter Steinberg; Scott A Rice; Staffan Kjelleberg
Journal:  Nat Rev Microbiol       Date:  2016-08-11       Impact factor: 60.633

Review 5.  A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa.

Authors:  J W Frew; D A Vekic; J Woods; G D Cains
Journal:  Br J Dermatol       Date:  2017-09-20       Impact factor: 9.302

6.  Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions.

Authors:  H H van der Zee; L de Ruiter; J Boer; D G van den Broecke; J C den Hollander; J D Laman; E P Prens
Journal:  Br J Dermatol       Date:  2011-12-05       Impact factor: 9.302

7.  Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.

Authors:  Olivier Join-Lambert; Hélène Coignard; Jean-Philippe Jais; Hélène Guet-Revillet; Sylvain Poirée; Sylvie Fraitag; Vincent Jullien; Florence Ribadeau-Dumas; Jacques Thèze; Anne-Sophie Le Guern; Sylvie Behillil; Anne Leflèche; Patrick Berche; Paul Henri Consigny; Olivier Lortholary; Xavier Nassif; Aude Nassif
Journal:  Dermatology       Date:  2010-11-25       Impact factor: 5.366

8.  Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa.

Authors:  G B Jemec; P Wendelboe
Journal:  J Am Acad Dermatol       Date:  1998-12       Impact factor: 11.527

9.  Bacterial pathogens associated with hidradenitis suppurativa, France.

Authors:  Hélène Guet-Revillet; Hélène Coignard-Biehler; Jean-Philippe Jais; Gilles Quesne; Eric Frapy; Sylvain Poirée; Anne-Sophie Le Guern; Anne Le Flèche-Matéos; Alain Hovnanian; Paul-Henry Consigny; Olivier Lortholary; Xavier Nassif; Aude Nassif; Olivier Join-Lambert
Journal:  Emerg Infect Dis       Date:  2014-12       Impact factor: 6.883

Review 10.  The Role of Skin and Orogenital Microbiota in Protective Immunity and Chronic Immune-Mediated Inflammatory Disease.

Authors:  Young Joon Park; Heung Kyu Lee
Journal:  Front Immunol       Date:  2018-01-10       Impact factor: 7.561

View more
  9 in total

1.  Proceeding report of the third symposium on Hidradenitis Suppurativa advances (SHSA) 2018.

Authors:  Claudia J Posso-De Los Rios; Akua Sarfo; Mondana Ghias; Raed Alhusayen; Iltefat Hamzavi; Michelle A Lowes; Afsaneh Alavi
Journal:  Exp Dermatol       Date:  2019-04-29       Impact factor: 3.960

Review 2.  Hidradenitis suppurativa.

Authors:  Robert Sabat; Gregor B E Jemec; Łukasz Matusiak; Alexa B Kimball; Errol Prens; Kerstin Wolk
Journal:  Nat Rev Dis Primers       Date:  2020-03-12       Impact factor: 52.329

3.  Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.

Authors:  Samuel Der Sarkissian; Schapoor Hessam; Joslyn S Kirby; Michelle A Lowes; Dillon Mintoff; Haley B Naik; Hans Christian Ring; Nisha Suyien Chandran; John W Frew
Journal:  JAMA Dermatol       Date:  2022-03-01       Impact factor: 11.816

4.  A systematic review and critical appraisal of metagenomic and culture studies in hidradenitis suppurativa.

Authors:  Samuel C Williams; John W Frew; James G Krueger
Journal:  Exp Dermatol       Date:  2020-08-11       Impact factor: 4.511

Review 5.  Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms.

Authors:  John W Frew; Jason E Hawkes; James G Krueger
Journal:  Ther Adv Chronic Dis       Date:  2019-03-01       Impact factor: 5.091

6.  Cytokine Pathways and Investigational Target Therapies in Hidradenitis Suppurativa.

Authors:  Ester Del Duca; Paola Morelli; Luigi Bennardo; Cosimo Di Raimondo; Steven Paul Nisticò
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

Review 7.  Efficacy and Toxicity of Classical Immunosuppressants, Retinoids and Biologics in Hidradenitis Suppurativa.

Authors:  Kinnor Das; Steven Daveluy; George Kroumpouzos; Komal Agarwal; Indrashis Podder; Katherine Farnbach; Alex G Ortega-Loayza; Jacek C Szepietowski; Stephan Grabbe; Mohamad Goldust
Journal:  J Clin Med       Date:  2022-01-27       Impact factor: 4.241

Review 8.  Microbiome in Hidradenitis Suppurativa-What We Know and Where We Are Heading.

Authors:  Zuzanna Świerczewska; Miłosz Lewandowski; Agnieszka Surowiecka; Wioletta Barańska-Rybak
Journal:  Int J Mol Sci       Date:  2022-09-24       Impact factor: 6.208

Review 9.  Hidradenitis Suppurativa: Current Understanding of Pathogenic Mechanisms and Suggestion for Treatment Algorithm.

Authors:  S Morteza Seyed Jafari; Robert E Hunger; Christoph Schlapbach
Journal:  Front Med (Lausanne)       Date:  2020-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.